Appendix 4E and Financial Report 2017
Filed with ASX · · 75 pages · English
The following information for Genetic Technologies Limited (“GTG” and the “Company”) is provided under Listing Rule 4.3A of the Listing Rules of the Australian Securities Exchange (“ASX”). The financial information provided in this Appendix 4E covers the consolidated Group, comprising Genetic Technologies Limited (the parent entity) and all entities that the Company controlled from time to time du
Genetic Technologies Limited on 6ix
Earlier from Genetic Technologies
- Comprehensive Review of Strategic Alternatives
- Breast Cancer Awareness Month Promotion for BREVAGenplus
- Quarterly Activities Report & Appendix 4C - 30 June 2017
- Nasdaq Deficiency Notice
- Quarterly Activities Report & Appendix 4C - 31 March 2017
Later from Genetic Technologies
- Transition to Online Commercial Platform for BREVAGenplus
- Quarterly Activities Report - 30 September 2017
- Update on Strategic Review Initiative
- Response to ASX Price Query
- Quarterly Activities Report & Appendix 4C - 31 December 2017
Follow Genetic Technologies into a list and get an email when it puts out news.
Follow Genetic Technologies